Clinical Utility of the Tokyo Guidelines 2018 for Acute Cholangitis in the Emergency Department and Comparison with Novel Markers (Neutrophil-to-Lymphocyte and Blood Nitrogen Urea-to-Albumin Ratios)

Hyun-Min Jung, Jinhui Paik, Minsik Lee, Yong Won Kim, Tae Youn KimJournal of Clinical Medicine 2024 · DOI

TL;DR

This study investigates the effectiveness of the Tokyo Guidelines 2018 (TG2018) scoring system in predicting clinical outcomes for acute cholangitis (AC) patients in the emergency department (ED). While TG2018 shows promise, particularly for predicting intensive care needs and endotracheal intubation, novel markers like the blood urea nitrogen-to-albumin ratio (BAR) also demonstrate utility, though with weaker explanatory power.

What Problem Does This Paper Address?

Acute cholangitis (AC) is a serious condition requiring prompt diagnosis and management, especially in the emergency department (ED) where efficiency is paramount. The Tokyo Guidelines 2018 (TG2018) provide a scoring system to guide AC management and predict severity. However, applying complex scoring systems in the fast-paced ED environment can be challenging. This study aims to evaluate the practical utility of the TG2018 score in the ED for predicting various clinical outcomes and to compare its predictive power against newer, potentially simpler biomarkers: the neutrophil-to-lymphocyte ratio (NLR) and the blood urea nitrogen-to-albumin ratio (BAR). The goal is to determine if these novel markers can offer comparable or complementary predictive value to the established TG2018 system.

Methods

This research employed a retrospective observational study design. Data from 502 patients diagnosed with acute cholangitis (AC) who visited the ED of a tertiary university hospital between January 2016 and December 2021 were analyzed. Patients were excluded if they lacked serum laboratory tests or were under 19 years old, resulting in a final cohort of 482 patients. The primary endpoints were to assess the TG2018 score's ability to predict the need for intensive care, long-term hospital stays (≥14 days), percutaneous transhepatic biliary drainage (PTBD), and endotracheal intubation (ETI). The study also compared the predictive performance of TG2018 with NLR and BAR. Statistical analyses included logistic regression to identify predictive factors and receiver operating characteristic (ROC) curve analysis to determine the area under the curve (AUC) for each marker.

Datasets

The study utilized retrospective data collected from the electronic medical records of 482 patients diagnosed with acute cholangitis (AC) who presented to the emergency department of a single tertiary university hospital between January 2016 and December 2021. No new datasets were introduced.

Key Insights and Ideas

  • TG2018's ED Utility: The TG2018 scoring system, even when applied in the ED setting, proves to be a valuable tool for predicting significant clinical outcomes in patients with acute cholangitis. This is crucial for resource allocation and early intervention planning.
  • Novel Markers Show Promise, But Not Superiority: While the BAR and NLR are associated with some adverse outcomes, their predictive power is generally weaker than TG2018, especially for more severe outcomes like ETI. This suggests they might serve as complementary indicators rather than replacements.
  • Intensive Care and ETI are Key Predictable Outcomes: The TG2018 system demonstrated particularly strong predictive capabilities for the need for intensive care and endotracheal intubation, areas where early and accurate prediction is critical.
  • BAR's Strength in ETI Prediction: Interestingly, the BAR emerged as the strongest predictor for endotracheal intubation, outperforming TG2018 in this specific outcome. This highlights the potential of simpler biomarkers for specific, high-acuity events.
  • Limitations of Novel Markers for Certain Outcomes: Despite their association with intensive care, BAR and NLR were not found to be significant predictors of long-term hospital stays or PTBD in the multilogistic regression analysis, limiting their broad applicability for these outcomes.

Key Results

  • The TG2018 score was a significant predictor for intensive care (adjusted OR for score 3 vs. 1 was 23.169), PTBD (adjusted OR for score 3 vs. 1 was 2.434), and ETI (adjusted OR for score 3 vs. 1 was 16.146).
  • For predicting the need for intensive care, TG2018 had the highest AUC (0.850) with a cutoff of >2.
  • The BAR showed the highest AUC (0.870) for predicting the need for endotracheal intubation (ETI) with a cutoff of >5.2. TG2018 also performed well for ETI (AUC 0.854).
  • For long-term hospital stays (≥14 days) and PTBD, the AUCs for all markers (TG2018, BAR, NLR, CRP) were generally below 0.7, indicating moderate predictive power.
  • While BAR and NLR were associated with intensive care and long-term hospital stays in univariate analysis, their predictive power was weaker compared to TG2018 in multilogistic regression for certain outcomes.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: This inherent limitation means potential for missing data and selection bias, making the findings less representative of the entire AC population.
  • Single-Center Study: The study was conducted at a single hospital, which may limit the generalizability of findings due to variations in patient populations and clinical practices.
  • Variability in Indications: Indications for intensive care and PTBD can differ between hospitals, potentially affecting the universal applicability of the results.
  • Confounding Factors: The retrospective nature makes it difficult to rule out all confounding factors that might influence outcomes like hospital stay duration, such as underlying medical conditions or post-discharge care arrangements.

Future work should focus on prospective, multi-center studies to validate these findings and explore the combined utility of TG2018 with novel markers. External validation is also recommended to confirm the generalizability of the proposed scoring systems and biomarkers.

Summary updated

Abstract

<b>Introduction</b>: The Tokyo Guidelines 2018 (TG2018) is a scoring system used to recommend the clinical management of AC. However, such a scoring system must incorporate a variety of clinical outcomes of acute cholangitis (AC). In an emergency department (ED)-based setting, where efficiency and practicality are highly desired, clinicians may find the application of various parameters challenging. The neutrophil-to-lymphocyte ratio (NLR) and blood urea nitrogen-to-albumin ratio (BAR) are relatively common biomarkers used to assess disease severity. This study evaluated the potential value of TG2018 scores measured in an ED to predict a variety of clinical outcomes. Furthermore, the study also compared TG2018 scores with NLR and BAR scores to demonstrate their usefulness. <b>Methods</b>: This retrospective observational study was performed in an ED. In total, 502 patients with AC visited the ED between January 2016 and December 2021. The primary endpoint was to evaluate whether the TG2018 scoring system measured in the ED was a predictor of intensive care, long-term hospital stays (≥14 days), percutaneous transhepatic biliary drainage (PTBD) during admission care, and endotracheal intubation (ETI). <b>Results</b>: The analysis included 81 patients requiring intensive care, 111 requiring long-term hospital stays (≥14 days), 49 requiring PTBD during hospitalization, and 14 requiring ETI during hospitalization. For the TG2018 score, the adjusted OR (aOR) using (1) as a reference was 23.169 (95% CI: 9.788-54.844) for (3) compared to (1). The AUC of the TG2018 for the need for intensive care was 0.850 (95% CI: 0.815-0.881) with a cutoff of >2. The AUC for long-term hospital stays did not exceed 0.7 for any of the markers. the AUC for PTBD also did not exceed 0.7 for any of the markers. The AUC for ETI was the highest for BAR at 0.870 (95% CI: 0.837-0.899) with a cutoff value of >5.2. <b>Conclusions</b>: The TG2018 score measured in the ED helps predict various clinical outcomes of AC. Other novel markers such as BAR and NLR are also associated, but their explanatory power is weak.
BibTeX
@article{jung2024clinical,
  author = {Hyun-Min Jung and Jinhui Paik and Minsik Lee and Yong Won Kim and Tae Youn Kim},
  title = {{Clinical Utility of the Tokyo Guidelines 2018 for Acute Cholangitis in the Emergency Department and Comparison with Novel Markers (Neutrophil-to-Lymphocyte and Blood Nitrogen Urea-to-Albumin Ratios)}},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  doi = {10.3390/jcm13082306},
}
Figure